AU2016335563B2 - Neural precursor cell populations and uses thereof - Google Patents

Neural precursor cell populations and uses thereof Download PDF

Info

Publication number
AU2016335563B2
AU2016335563B2 AU2016335563A AU2016335563A AU2016335563B2 AU 2016335563 B2 AU2016335563 B2 AU 2016335563B2 AU 2016335563 A AU2016335563 A AU 2016335563A AU 2016335563 A AU2016335563 A AU 2016335563A AU 2016335563 B2 AU2016335563 B2 AU 2016335563B2
Authority
AU
Australia
Prior art keywords
cells
neural precursor
cell
population
neural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016335563A
Other languages
English (en)
Other versions
AU2016335563A1 (en
Inventor
Marina BERSHTEYN
Stuart Chambers
Luis FUENTEALBA
Sonja KRIKS
Cory NICHOLAS
Cheuk Ka TONG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurona Therapeutics Inc
Original Assignee
Neurona Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurona Therapeutics Inc filed Critical Neurona Therapeutics Inc
Publication of AU2016335563A1 publication Critical patent/AU2016335563A1/en
Application granted granted Critical
Publication of AU2016335563B2 publication Critical patent/AU2016335563B2/en
Priority to AU2023200389A priority Critical patent/AU2023200389B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2016335563A 2015-10-08 2016-10-10 Neural precursor cell populations and uses thereof Active AU2016335563B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023200389A AU2023200389B2 (en) 2015-10-08 2023-01-25 Neural precursor cell populations and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562239042P 2015-10-08 2015-10-08
US62/239,042 2015-10-08
PCT/US2016/056316 WO2017062971A1 (en) 2015-10-08 2016-10-10 Neural precursor cell populations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023200389A Division AU2023200389B2 (en) 2015-10-08 2023-01-25 Neural precursor cell populations and uses thereof

Publications (2)

Publication Number Publication Date
AU2016335563A1 AU2016335563A1 (en) 2018-05-24
AU2016335563B2 true AU2016335563B2 (en) 2022-10-27

Family

ID=57200130

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2016335563A Active AU2016335563B2 (en) 2015-10-08 2016-10-10 Neural precursor cell populations and uses thereof
AU2023200389A Active AU2023200389B2 (en) 2015-10-08 2023-01-25 Neural precursor cell populations and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023200389A Active AU2023200389B2 (en) 2015-10-08 2023-01-25 Neural precursor cell populations and uses thereof

Country Status (8)

Country Link
US (1) US20180369287A1 (enExample)
EP (1) EP3359647A1 (enExample)
JP (4) JP2018529389A (enExample)
CN (1) CN108291207A (enExample)
AU (2) AU2016335563B2 (enExample)
CA (1) CA3001316A1 (enExample)
HK (1) HK1258172A1 (enExample)
WO (1) WO2017062971A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11767507B2 (en) 2013-11-08 2023-09-26 The Mclean Hospital Corporation Methods for efficient generation of GABAergic interneurons from pluripotent stem cells
JP2022043373A (ja) * 2018-12-28 2022-03-16 国立大学法人京都大学 大脳皮質細胞からのｌ１ｃａｍ陽性細胞の取得およびその細胞製剤としての使用
US12343359B2 (en) 2019-05-23 2025-07-01 Dignity Health Inhibitory interneuron treatment methods, uses and compositions for diabetes
US20250082689A1 (en) * 2021-07-21 2025-03-13 University Of Washington Compositions and methods for enhancing cardiomyocyte transplant engraftment
KR102684884B1 (ko) * 2021-08-05 2024-07-15 성균관대학교산학협력단 신경줄기세포의 줄기세포능 증진을 위한 gng2의 용도
CN113826564A (zh) * 2021-08-31 2021-12-24 南通大学 一种检测小鼠运动能力的方法
CN114736957B (zh) * 2022-04-15 2024-03-12 中国人民解放军空军军医大学 外泌体介导rna casc15干预阿尔茨海默症突触损失的应用
WO2025075929A1 (en) * 2023-10-02 2025-04-10 Neurona Therapeutics Inc. Methods of treating seizure activity
CN117092354B (zh) * 2023-10-18 2023-12-29 亿航(苏州)生物医药有限公司 一种用于识别脑源性细胞的细胞外囊泡的蛋白标志物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153230A1 (en) * 2013-03-14 2014-09-25 The Regents Of The University Of California In vitro production of medial ganglionic eminence precursor cells

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
CA2409698C (en) 2000-05-17 2010-10-26 Geron Corporation Neural progenitor cell populations
EP2298867A3 (en) 2000-06-20 2013-01-16 ES Cell International Pte Ltd. Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
AU2003281309A1 (en) 2002-07-05 2004-01-23 Kirin Beer Kabushiki Kaisha Novel undifferentiated stem cells contained in cord blood, bone marrow, peripheral blood or the like
US20060211111A1 (en) 2002-12-18 2006-09-21 Maisam Mitalipova Compositions and methods for neural cell production and stabilization
ZA200401646B (en) * 2003-03-12 2004-06-07 Reliance Life Sciences Pvt Ltd Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.
WO2004099395A2 (en) 2003-05-08 2004-11-18 Cellartis Ab A method for the generation of neural progenitor cells
US7820439B2 (en) 2003-09-03 2010-10-26 Reliance Life Sciences Pvt Ltd. In vitro generation of GABAergic neurons from pluripotent stem cells
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
JP2008501320A (ja) 2004-06-02 2008-01-24 イーエス・セル・インターナショナル・プライヴェート・リミテッド 細胞保存方法
WO2006014551A2 (en) 2004-07-06 2006-02-09 Michigan State University In vivo methods for effecting tissue specific differentiation of embryonic stem cells
EP1856248A4 (en) 2005-02-09 2010-01-20 Burnham Inst Medical Research HOMOGENEOUS NEURALE CURRENT CELLS
US7642091B2 (en) 2005-02-24 2010-01-05 Jau-Nan Lee Human trophoblast stem cells and use thereof
US7803364B2 (en) 2005-11-17 2010-09-28 The Cleveland Clinic Foundation Multipotent neural stem cells
CN103952373A (zh) 2005-12-08 2014-07-30 路易斯维尔大学研究基金会有限公司 非常小的胚胎样(vsel)干细胞及分离和利用其的方法
US9192630B2 (en) 2006-01-20 2015-11-24 The Regents Of The University Of California Transplantation of neural cells
RS57083B1 (sr) 2006-11-03 2018-06-29 Multiple Sclerosis Res Center Of New York Mezenhimske matične ćelije dobijene iz koštane srži kao izvor progenitora neuralnih ćelija
EP2607477B1 (en) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20100287638A1 (en) 2007-10-01 2010-11-11 The Hospital For Sick Children Neural tumor stem cells and methods of use thereof
US20110165129A1 (en) 2008-05-06 2011-07-07 Arnold Kriegstein Ameliorating Nervous Systems Disorders
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
KR20110015739A (ko) 2009-08-10 2011-02-17 삼성전자주식회사 Ｅｍｉ방사 저감을 위한 플라즈마 디스플레이 장치
WO2011079307A2 (en) 2009-12-23 2011-06-30 The Salk Institute For Biological Studies Methods and compositions for treating neurological disorders
US9057053B2 (en) 2010-01-19 2015-06-16 The Board Of Trustees Of The Leland Stanford Junior University Direct conversion of cells to cells of other lineages
US9717761B2 (en) 2011-11-21 2017-08-01 Ramot At Tel-Aviv University Ltd. Stem cell-derived neural cells for cell therapy in neurological disorders
KR101429217B1 (ko) 2012-02-06 2014-08-12 동국대학교 산학협력단 줄기세포를 신경세포로 분화시키는 방법
WO2013139429A1 (en) 2012-03-21 2013-09-26 Merck Patent Gmbh Induced neural stem cells
WO2013155222A2 (en) 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
JP2014082956A (ja) 2012-10-19 2014-05-12 Somar Corp 細胞培養基材、およびそれを用いた細胞培養方法並びに多能性幹細胞の分化誘導方法
EP2989198A4 (en) 2013-04-26 2016-10-26 Sloan Kettering Inst Cancer CORTICAL INTERNETS AND OTHER NEURONAL CELLS MADE BY TARGETED DIFFERENTIATION OF PLURIPOTENTAL AND MULTIPOTENTIAL CELLS
EP3690032A1 (en) 2013-09-20 2020-08-05 Lonza Ltd. Methods for nuclear reprogramming of cells
US11767507B2 (en) 2013-11-08 2023-09-26 The Mclean Hospital Corporation Methods for efficient generation of GABAergic interneurons from pluripotent stem cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153230A1 (en) * 2013-03-14 2014-09-25 The Regents Of The University Of California In vitro production of medial ganglionic eminence precursor cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nicholas, C. R., et al., (2013). Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell stem cell, 12(5), 573–586. *

Also Published As

Publication number Publication date
AU2016335563A1 (en) 2018-05-24
JP2018529389A (ja) 2018-10-11
AU2023200389A1 (en) 2023-02-23
US20180369287A1 (en) 2018-12-27
JP7598655B2 (ja) 2024-12-12
HK1258172A1 (zh) 2019-11-08
AU2023200389B2 (en) 2025-09-25
JP2020202865A (ja) 2020-12-24
JP2022169768A (ja) 2022-11-09
CA3001316A1 (en) 2017-04-13
CN108291207A (zh) 2018-07-17
EP3359647A1 (en) 2018-08-15
JP2025022948A (ja) 2025-02-14
JP7138959B2 (ja) 2022-09-20
WO2017062971A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
AU2016335563B2 (en) Neural precursor cell populations and uses thereof
Shibata et al. Regulation of prefrontal patterning and connectivity by retinoic acid
US12178834B2 (en) Treating myelin diseases with optimized cell preparations
Assinck et al. Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury
Bershteyn et al. Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy
Lang et al. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells
Proietti et al. Activation of skeletal muscle–resident glial cells upon nerve injury
Nizzardo et al. iPSC-derived LewisX+ CXCR4+ β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models
CN105960453A (zh) 从人多能干细胞定向分化星形胶质细胞用于肌萎缩侧索硬化(als)的治疗和药物筛选
Xu et al. Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche
US20240207324A1 (en) Method for quality control and enrichment of human dopaminergic neural precursor cells
Bershteyn et al. Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity followed by gradual electrochemical maturation
Hattiangady et al. Neural stem cell grafting in an animal model of chronic temporal lobe epilepsy
JP2021084882A (ja) 脊髄損傷治療用ニューロスフェア誘導剤及びその使用
WO2025075929A1 (en) Methods of treating seizure activity
Honsa Neurogeneze a gliogeneze v dospělém mozku po ischemickém poškození
Grow Neural cell fate in the context of improving translational medicine
Li Role of Tyrosine Receptor Kinase B in the Development and Function of the Central Nervous System
Ng et al. Isolation of GABAergic Cortical Neurons and Implications for Cell Transplantation Strategies in the Nervous System
Sommer Modeling Neuroinflammation in sporadic Parkinson ́s disease
Mackay-Sim Olfactory mucosa: Neural stem and progenitor cells for nervous system repair and cell models of brain disease
LI ROLE OF TYROSINE RECEPTOR KINASE B IN THE DEVELOPMENT AND

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)